BioHarvest Sciences Inc. Common Stock (BHST) Stock

BioHarvest Sciences Inc. Common Stock (BHST) is a Healthcare stock trading at $3.50 (as of 2026-06-15), with a market capitalization of $82.05M and a trailing P/E of -6.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.

Valuation — source: SEC EDGAR (first-party)
Price$3.50
Market Cap$82.05M
P/E Ratio-6.6
EV / EBITDA-12.9
Price / Book2.90
Price / Sales2.14
DCF Value (model)$-6.19
DCF Upside vs Price-277.1%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$34.51M
Net Margin-32.3%
Return on Equity-43.8%
Debt / Equity0.01
Current Ratio3.97
Revenue Growth (YoY)37.0%
EPS Growth (YoY)-25.0%
FCF Growth (YoY)0.7%
Financial Health — source: SEC EDGAR
Altman Z-Score-0.11 (distress)
Piotroski F-Score5/9 (moderate)
Valuation vs Sector & Industry
Stock P/E-6.6
Sector P/E (Healthcare)20.9
Industry P/E (Pharmaceutical Products)17.0
vs Sector-131.8%
vs Industry-139.0%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderAlyeska Investment Group, L.P. ($3.29M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOIlan Sobel
Employees87
CountryCA
IPO Date2021-01-08

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Acumen Pharmaceuticals, Inc. (ABOS)
  • Dogwood Therapeutics, Inc. (DWTX)
  • Coya Therapeutics, Inc. (COYA)
  • Sol-Gel Technologies Ltd. (SLGL)
  • Inovio Pharmaceuticals, Inc. (INO)
  • Cognition Therapeutics, Inc. (CGTX)
  • Spruce Biosciences, Inc. (SPRB)
  • Fortress Biotech, Inc. (FBIO)
BHST earnings history · BHST institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-15.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.